Sensory Anesthesia Achieved Through Different Paravertebral Block Approaches for Post-Op Pain Management After VATS Lung Resection
1 other identifier
observational
90
1 country
1
Brief Summary
Video-assisted thoracoscopic lung resection (VATS) is a minimally invasive surgical approach frequently used in the treatment of lung cancers. The most commonly used analgesic technique for this surgery is the paravertebral block with a single peroperative injection of local anesthetic. However, a recent study conducted at our institution revealed that this approach provided less relief than expected in some patients. In light of these results, it becomes crucial to distinguish between technical failures (absence of sensitive anesthesia) and the intrinsic limits of the chosen regional analgesia technique (pain originating from an unanesthetized area or pain despite the presence of sensitive anesthesia) in order to better relieve patients. This study aims to objectively assess the areas of anesthesia obtained through three methods of paravertebral block to evaluate their respective performance and optimize post-VATS analgesic management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2025
CompletedFirst Posted
Study publicly available on registry
July 14, 2025
CompletedStudy Start
First participant enrolled
September 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 10, 2026
February 27, 2026
February 1, 2026
1 year
June 30, 2025
February 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Success rate of the sensory block
The success rate of the sensory block, defined as a hypoesthetic level to ice or the Von Frey filament of at least T3 to T8 in the recovery room, assessed at mid-scapular, mid-axillary, and mid-clavicular.
One hour after the surgery
Secondary Outcomes (9)
Severity of acute postoperative pain
One hour after the surgery
Postoperative morphine-equivalents consumption
Perioperative
Total duration in the operating room
At the end of the surgery
Time to recovery room discharge
24 hours
Quality of the local anesthetic diffusion
After the parabertebral block, during the surgery
- +4 more secondary outcomes
Study Arms (1)
Paravertebral block using percutaneous, transpleural or ultrasound guidance technique
The investigators aim to conduct a prospective observational study including patients having a paravertebral block undergoing a VATS lung surgery. The paravertebral block administration technique will vary sequentially, meaning that the first 30 patients included will receive the percutaneous technique, and the next 30 will receive the transpleural technique by the surgeon. The other 30 patients will receive the paravertebral block under ultrasound guidance by the anesthesiologist. Paravertebral block will be administered at two levels, T4 and T7, using the percutaneous, the transpleural or ultrasound guided technique. It will be administered by the surgeon (percutaneous and transpleural) or by the anesthesiologist (ultrasound guided) directly after the installation of the thoracoscope and before the start of lung and lymph node resection. The local anesthetic will be bupivacaine 0.5% with 5 mcg/mL of adrenaline for a total volume of 0.4 mL/kg.
Interventions
In the recovery room, a member of the research team will come to assess the presence of hypoesthesia (loss of sensation) of the thorax using ice and a Von Frey filament applied at three different sections: midscapular, midaxillary and midclavicular.
Eligibility Criteria
Patients scheduled for elective anatomical pulmonary resection by VATS at two institutions
You may qualify if:
- Patients aged 18 years and older
- American Society of Anesthesiologists (ASA) score 1-3
You may not qualify if:
- Contraindication to the paravertebral block (coagulopathy, use of anticoagulants or antiplatelet agents other than aspirin that have not been stopped according to hospital guidelines, thoracoscopic visualization of the paravertebral space expected to be difficult or impossible, anterior spinal surgery with potential discontinuity of the paravertebral space)
- Epidural analgesia preferred (high risk of thoracotomy, marginal lung function)
- Surgical criteria: conversion to thoracotomy necessary and thoracic epidural or other form of regional analgesia implemented post-operatively
- Known allergy to local anesthetics
- Language barrier, psychiatric, physical or mental condition making pain assessment impossible despite prior education
- Pregnancy
- Patient refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, H2X 3E4, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Alex Moore, MD
Centre hospitalier de l'Université de Montréal (CHUM)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2025
First Posted
July 14, 2025
Study Start
September 10, 2025
Primary Completion (Estimated)
September 10, 2026
Study Completion (Estimated)
September 10, 2026
Last Updated
February 27, 2026
Record last verified: 2026-02